ACDM News Item

Welcome P95 as a corporate member

Date: September 8, 2025

The ACDM: Association for Clinical Data Management is delighted to welcome P95 as a new corporate member.

P95 is a leading global provider of comprehensive clinical trial services, epidemiology, and real-world evidence (RWE) solutions, with a specialized focus on vaccine development and infectious diseases. They operate on five continents, providing tailored clinical research solutions across 40 countries. P95’s commitment to flexibility, client focus, and excellence drives them to deliver solutions that make a meaningful impact on public health worldwide.

P95 joined the ACDM to support training for its team members and to ensure they are part of a vibrant professional community.

Members gain many benefits from membership, including:

Access to training courses at a discounted rate
Assign full ACDM membership to all individuals within your organisation
Place an organisation profile, description and logo on the ACDM website
Advertise jobs for your positions within your organisation
Reduced price attendance at conferences and symposia
Free attendance at Hot Topics

Find out more about becoming a corporate member here.

Explore More News

Regulatory Considerations DMEG Shares Update on ICH E6(R3) Training Modules Available

The ICH Working Groups and The ICH Training Associates have released two new training . . .

Recent update from the regulatory landscape in clinical data management

On 22 September, MHRA published a new set of inspection dossier documents specifically for . . .

Regulatory Considerations DMEG Update – August 2026

Please read the following update from the Regulatory Considerations DMEG: July and . . .

Get to know ACDM Board Member: Santosh Karthikeyan Viswanathan

We caught up with one of ACDM’s new Board Members, Santosh Karthikeyan Viswanathan, to . . .

Guidance on Decentralized Clinical Trials to be Reviewed by the ACDM RC DMEG

Health Canada (HC) continues to publish new guidelines to support their modernization of . . .

Regulatory Considerations DMEG to Review Health Canada’s Draft Guidance

Thank you to the Regulatory Considerations DMEG for sharing this update. Health Canada . . .

Recent update from the regulatory landscape in clinical data management

Thank you to the Regulatory Considerations DMEG for sharing this update. On July 15 the . . .

Regulatory Considerations DMEG Update – June 2026

Please read the following update from the Regulatory Considerations DMEG: Regulators have . . .

FDA Announces New Initiative for Real-Time Clinical Trials

The U.S. Food and Drug Administration (FDA) has announced a new initiative to support the . . .

Get to know ACDM Board Member Jennifer Duff

We caught up with one of ACDM’s new Board Members, Jennifer Duff, to learn more about her. . . .

Recent News in Regulatory Landscape

The ACDM Regulatory Considerations DMEG have kindly put together a short news piece . . .

Real-Time Clinical Data Flow: Why the FDA’s New Pilot Validates the Data Flow Modernization Agenda

Tamer Chowdhury, on behalf of ACDM Technology DMEG. On April 28, FDA Commissioner Dr. . . .